Basic fibroblast growth factor causes urinary bladder overactivity through gap junction generation in the smooth muscle

1 Department of Urology, Graduate School of Medicine, and 2 Department of Biomaterials, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan; and 3 Department of Urology, Hyogo Medical College, Nishinomiya, Japan Submitted 23 March 2008 ; accepted in final form 16 April 2009 Overa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Renal physiology 2009-07, Vol.297 (1), p.F46-F54
Hauptverfasser: Imamura, Masaaki, Negoro, Hiromitsu, Kanematsu, Akihiro, Yamamoto, Shingo, Kimura, Yu, Nagane, Kentaro, Yamasaki, Toshinari, Kanatani, Isao, Ito, Noriyuki, Tabata, Yasuhiko, Ogawa, Osamu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:1 Department of Urology, Graduate School of Medicine, and 2 Department of Biomaterials, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan; and 3 Department of Urology, Hyogo Medical College, Nishinomiya, Japan Submitted 23 March 2008 ; accepted in final form 16 April 2009 Overactive bladder is a highly prevalent clinical condition that is often caused by bladder outlet obstruction (BOO). Increased coupling of bladder smooth muscle cells (BSMC) via gap junctions has been hypothesized as a mechanism for myogenic bladder overactivity in BOO, although little is known about the regulatory system underlying such changes. Here, we report the involvement of basic fibroblast growth factor (bFGF) and connexin 43, a bladder gap junction protein, in bladder overactivity. BOO created by urethral constriction in rats resulted in elevated bFGF and connexin 43 levels in the bladder urothelium and muscle layer, respectively, and muscle strips from these bladders were more sensitive than those from sham-operated controls to a cholinergic agonist. In vitro bFGF treatment increased connexin 43 expression in cultured rat BSMC via the ERK 1/2 pathway. This finding was supported by another in vivo model, where bFGF released from gelatin hydrogels fixed on rat bladder walls caused connexin 43 upregulation and gap junction formation in the muscle layer. Bladder muscle strips in this model showed increased sensitivity to a cholinergic agonist that was blocked by inhibition of gap junction function with -glycyrrhetinic acid. Cystometric analyses of this model showed typical features of detrusor overactivity such as significantly increased micturition frequency and decreased bladder capacity. These findings suggest that bFGF from the urothelium could induce bladder hypersensitivity to acetylcholine via gap junction generation in the smooth muscle, thereby contributing to the myogenic overactivity of obstructed bladders. bFGF; bladder smooth muscle cell; connexin 43; ERK; hypersensitivity Address for reprint requests and other correspondence: O. Ogawa, Dept. of Urology, Graduate School of Medicine, Kyoto Univ. School of Medicine, Sakyo-ku, Shogoin-kawahara-cho 54, Kyoto, 606-8507 Japan (e-mail: ogawao{at}kuhp.kyoto-u.ac.jp )
ISSN:0363-6127
1931-857X
2161-1157
1522-1466
DOI:10.1152/ajprenal.90207.2008